NIH-funded research R03 grant

Creating a new model to study tau protein toxicity using yeast

Official title: Developing and Validating a Novel Tau Toxicity Model in the Budding Yeast

Funded at Baylor College of Medicine · NIH-10745344 · Data updated 2026-11-12

This study is looking at how certain proteins related to dementia can become harmful in cells, using a type of yeast to see how these proteins behave and what genes might affect their toxicity, which could help us find new ways to treat these brain diseases.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startDecember 1, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$160,000
NIH project number5R03AG080423-02
Project IDNIH-10745344 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by tauopathies, such as Alzheimer's disease or frontotemporal dementia.

Less likely to help

Patients with tauopathies who are not interested in research participation or those with other unrelated neurodegenerative conditions may not benefit from this research.

What this research studies

This research investigates how tau proteins, which are linked to various forms of dementia, become toxic in cells. By using the budding yeast Saccharomyces cerevisiae, researchers will overexpress human tau proteins to observe their effects and identify genetic factors that may influence tau toxicity. This approach allows for powerful genetic screening to uncover the molecular pathways involved in tau-related neurodegenerative diseases. The findings could lead to a better understanding of tauopathies and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for neurodegenerative diseases associated with tau protein toxicity.

How similar studies have gone: Previous research using yeast models has successfully identified genetic modifiers of other neurodegenerative diseases, suggesting this approach may yield valuable insights.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Dang, Weiwei — Baylor College of Medicine
  • Study coordinator: Dang, Weiwei

Related research

Other NIH-funded projects on the same topics.

  • Multimodal AI to improve genetic diagnosis of congenital heart disease

    A new AI tool uses multiple types of patient data to help doctors find genetic causes of congenital heart disease more accurately.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11625643

  • Surveillance of Vaccine-Preventable Diseases in Children

    This project watches how often common vaccines prevent illnesses in kids who are in the hospital or at the emergency department, and compares them with healthy children getting well-child care.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11624114

  • Triple gene therapy approach to heal the heart after a heart attack

    A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11621120

  • Thalamic sleep circuit changes in Alzheimer's disease

    Aims to understand how sleep-related brain activity in a key sleep regulator called the TRN affects Alzheimer’s progression and whether boosting TRN function could slow symptoms.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11617739

  • Cardiomyocyte-fibroblast signaling in atrial fibrillation

    A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11617730

  • UMPIRE: Keeping Kidneys Healthy for Babies with Spina Bifida

    A care protocol for newborns with spina bifida aims to protect kidney function by thoughtful bladder management and monitoring from birth.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11616581

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.